{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T20:04:44Z","timestamp":1773345884678,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006261","name":"Taif University","doi-asserted-by":"publisher","award":["TU-DSPP-2024-156"],"award-info":[{"award-number":["TU-DSPP-2024-156"]}],"id":[{"id":"10.13039\/501100006261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03151-2","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T17:08:48Z","timestamp":1749229728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanosizing and Surface Modification by Propellant Assisted Aerosolization Enhances Solubility and Dissolution of Estradiol"],"prefix":"10.1208","volume":"26","author":[{"given":"Gaurav K.","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Akhlaquer","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9071-8889","authenticated-orcid":false,"given":"Musarrat Husain","family":"Warsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Imran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"3151_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jconrel.2017.06.003","volume":"260","author":"R Al-Kassas","year":"2017","unstructured":"Al-Kassas R, Bansal M, Shaw J. Nanosizing techniques for improving bioavailability of drugs. J Control Release. 2017;260:202\u201312.","journal-title":"J Control Release"},{"issue":"2","key":"3151_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0928-0987(02)00251-8","volume":"18","author":"E Merisko-Liversidge","year":"2003","unstructured":"Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003;18(2):113\u201320.","journal-title":"Eur J Pharm Sci"},{"key":"3151_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2018.05.002","volume":"131","author":"F Fontana","year":"2018","unstructured":"Fontana F, Figueiredo P, Zhang P, Hirvonen JT, Liu D, Santos HA. Production of pure drug nanocrystals and nano co-crystals by confinement methods. Adv Drug Deliv Rev. 2018;131:3\u201321.","journal-title":"Adv Drug Deliv Rev"},{"key":"3151_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1208\/s12249-022-02475-7","volume":"24","author":"G Wang","year":"2022","unstructured":"Wang G, Li Y, Qin Z, Liu T. Nanosizing coamorphous drugs using top-down approach: the effect of particle size reduction on dissolution improvement. AAPS PharmSciTech. 2022;24:14.","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"3151_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/polym14020286","volume":"14","author":"A Kramar","year":"2022","unstructured":"Kramar A, Gonz\u00e1lez-Benito FJ. Cellulose-based nanofibers processing techniques and methods based on bottom-up approach-a review. Polymers (Basel). 2022;14(2):286.","journal-title":"Polymers (Basel)"},{"key":"3151_CR6","doi-asserted-by":"publisher","first-page":"116798","DOI":"10.1016\/j.ejmech.2024.116798","volume":"279","author":"S Dong","year":"2024","unstructured":"Dong S, Li X, Pan Q, Wang K, Liu N, Yutao W, Zhang Y. Nanotechnology-based approaches for antibacterial therapy. Eur J Med Chem. 2024;279:116798.","journal-title":"Eur J Med Chem"},{"issue":"12","key":"3151_CR7","doi-asserted-by":"publisher","first-page":"9824","DOI":"10.3390\/ijms24129824","volume":"24","author":"G Zuccari","year":"2023","unstructured":"Zuccari G, Alfei S. Development of phytochemical delivery systems by nano-suspension and nano-emulsion techniques. Int J Mol Sci. 2023;24(12):9824.","journal-title":"Int J Mol Sci"},{"key":"3151_CR8","first-page":"265754","volume":"2014","author":"J Salazar","year":"2014","unstructured":"Salazar J, M\u00fcller RH, M\u00f6schwitzer J. Combinative particle size reduction technologies for the production of drug nanocrystals. J Pharm (Cairo). 2014;2014:265754.","journal-title":"J Pharm (Cairo)"},{"issue":"7","key":"3151_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1089\/adt.2021.053","volume":"19","author":"AA \u00d6zt\u00fcrk","year":"2021","unstructured":"\u00d6zt\u00fcrk AA, Arpagaus C. Nano spray-dried drugs for oral administration: a review. Assay Drug Dev Technol. 2021;19(7):412\u201341.","journal-title":"Assay Drug Dev Technol"},{"issue":"3","key":"3151_CR10","doi-asserted-by":"publisher","first-page":"e202107960","DOI":"10.1002\/anie.202107960","volume":"61","author":"N Tiwari","year":"2022","unstructured":"Tiwari N, Osorio-Blanco ER, Sonzogni A, Esporr\u00edn-Ubieto D, Wang H, Calder\u00f3n M. Nanocarriers for skin applications: where do we stand? Angew Chem Int Ed Engl. 2022;61(3):e202107960.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"4","key":"3151_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/17425247.2018.1444025","volume":"15","author":"V Patel","year":"2018","unstructured":"Patel V, Sharma OP, Mehta T. Nanocrystal: a novel approach to overcome skin barriers for improved topical drug delivery. Expert Opin Drug Deliv. 2018;15(4):351\u201368.","journal-title":"Expert Opin Drug Deliv"},{"issue":"19","key":"3151_CR12","doi-asserted-by":"publisher","first-page":"e1704463","DOI":"10.1002\/adma.201704463","volume":"30","author":"D Septiadi","year":"2018","unstructured":"Septiadi D, Crippa F, Moore TL, Rothen-Rutishauser B, Petri-Fink A. Nanoparticle-cell interaction: a cell mechanics perspective. Adv Mater. 2018;30(19):e1704463.","journal-title":"Adv Mater"},{"key":"3151_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40005-022-00607-6","volume":"53","author":"RK Thapa","year":"2023","unstructured":"Thapa RK, Kim JO. Nanomedicine-based commercial formulations: current developments and future prospects. J Pharm Investig. 2023;53:19\u201333.","journal-title":"J Pharm Investig"},{"issue":"1","key":"3151_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/pharmaceutics14010106","volume":"14","author":"AA Halwani","year":"2022","unstructured":"Halwani AA. Development of pharmaceutical nanomedicines: from the bench to the market. Pharmaceutics. 2022;14(1):106.","journal-title":"Pharmaceutics"},{"key":"3151_CR15","doi-asserted-by":"publisher","first-page":"119098","DOI":"10.1016\/j.ijpharm.2020.119098","volume":"578","author":"S Bisso","year":"2020","unstructured":"Bisso S, Leroux JC. Nanopharmaceuticals: a focus on their clinical translatability. Int J Pharm. 2020;578:119098.","journal-title":"Int J Pharm"},{"key":"3151_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s43094-022-00400-0","volume":"8","author":"ZM Mazayen","year":"2022","unstructured":"Mazayen ZM, Ghoneim AM, Elbatanony RS, Basalious ER. Pharmaceutical nanotechnology: from the bench to the market. Futur J Pharm Sci. 2022;8:12.","journal-title":"Futur J Pharm Sci"},{"issue":"9","key":"3151_CR17","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.2147\/IJN.S46900","volume":"15","author":"V Weissig","year":"2014","unstructured":"Weissig V, Pettinger TK, Murdock N. Nanopharmaceuticals (part 1): products on the market. Int J Nanomedicine. 2014;15(9):4357\u201373.","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"3151_CR18","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.drudis.2022.02.022","volume":"27","author":"L S\u00e9guy","year":"2022","unstructured":"S\u00e9guy L, Groo AC, Malzert-Fr\u00e9on A. How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer\u2019s disease treatment? Drug Discov Today. 2022;27(6):1575\u201389.","journal-title":"Drug Discov Today"},{"issue":"1","key":"3151_CR19","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1515\/ntrev-2021-0115","volume":"10","author":"AH Abdellatif","year":"2021","unstructured":"Abdellatif AH, Alsowinea FA. Approved and marketed nanoparticles for disease targeting and applications in COVID-19. Nanotech Rev. 2021;10(1):1941\u201377.","journal-title":"Nanotech Rev"},{"issue":"7","key":"3151_CR20","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1016\/j.apsb.2022.02.025","volume":"12","author":"X Shan","year":"2022","unstructured":"Shan X, Gong X, Li J, Wen J, Li Y, Zhang Z. Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharm Sin B. 2022;12(7):3028\u201348.","journal-title":"Acta Pharm Sin B"},{"key":"3151_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jconrel.2020.12.034","volume":"330","author":"V Gadekar","year":"2021","unstructured":"Gadekar V, Borade Y, Kannaujia S, Rajpoot K, Anup N, Tambe V, Kalia K, Tekade RK. Nanomedicines accessible in the market for clinical interventions. J Control Release. 2021;330:372\u201397.","journal-title":"J Control Release"},{"issue":"3","key":"3151_CR22","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/pharmaceutics15030774","volume":"15","author":"Y Jia","year":"2023","unstructured":"Jia Y, Jiang Y, He Y, Zhang W, Zou J, Magar KT, Boucetta H, Teng C, He W. Approved Nanomedicine against Diseases. Pharmaceutics. 2023;15(3):774.","journal-title":"Pharmaceutics"},{"issue":"4","key":"3151_CR23","first-page":"1335","volume":"16","author":"R Teymouri Rad","year":"2017","unstructured":"Teymouri Rad R, Mortazavi SA, Vatanara A, Dadashzadeh S. Enhanced dissolution rate of tadalafil nanoparticles prepared by sonoprecipitation technique: optimization and physicochemical investigation. Iran J Pharm Res. 2017;16(4):1335\u201348.","journal-title":"Iran J Pharm. Res."},{"issue":"1","key":"3151_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.nano.2008.07.001","volume":"5","author":"R Ali","year":"2009","unstructured":"Ali R, Jain GK, Iqbal Z, Talegaonkar S, Pandit P, Sule S, Malhotra G, Khar RK, Bhatnagar A, Ahmad FJ. Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote. Nanomedicine. 2009;5(1):55\u201363.","journal-title":"Nanomedicine"},{"issue":"2","key":"3151_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ejpb.2008.09.018","volume":"71","author":"FJ Ahmad","year":"2009","unstructured":"Ahmad FJ, Mittal G, Jain GK, Malhotra G, Khar RK, Bhatnagar A. Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions. Eur J Pharm Biopharm. 2009;71(2):282\u201391.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"3151_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1208\/s12249-021-01963-6","volume":"22","author":"NV Gandhi","year":"2021","unstructured":"Gandhi NV, Deokate UA, Angadi SS. Development of nanonized nitrendipine and its transformation into nanoparticulate oral fast dissolving drug delivery system. AAPS PharmSciTech. 2021;22(3):113.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"3151_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/pharmaceutics12050476","volume":"12","author":"A Bonaccorso","year":"2020","unstructured":"Bonaccorso A, Gigliobianco MR, Pellitteri R, Santonocito D, Carbone C, Di Martino P, Puglisi G, Musumeci T. Optimization of curcumin nanocrystals as promising strategy for nose-to-brain delivery application. Pharmaceutics. 2020;12(5):476.","journal-title":"Pharmaceutics"},{"issue":"13","key":"3151_CR28","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.3390\/ma17133240","volume":"17","author":"M Stec","year":"2024","unstructured":"Stec M, Synowiec PM, Stolarczyk A. Synthesis of HAp by means of sonoprecipitation method. Materials (Basel). 2024;17(13):3240.","journal-title":"Materials (Basel)"},{"issue":"5","key":"3151_CR29","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3390\/pharmaceutics15051520","volume":"15","author":"SG P\u0131nar","year":"2023","unstructured":"P\u0131nar SG, Oktay AN, Karak\u00fc\u00e7\u00fck AE, \u00c7elebi N. Formulation strategies of nanosuspensions for various administration routes. Pharmaceutics. 2023;15(5):1520.","journal-title":"Pharmaceutics"},{"issue":"4","key":"3151_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/pharmaceutics16040471","volume":"16","author":"TL Roldan","year":"2024","unstructured":"Roldan TL, Li S, Guillon C, Heindel ND, Laskin JD, Lee IH, Gao D, Sinko PJ. Optimizing nanosuspension drug release and wound healing using a design of experiments approach: improving the drug delivery potential of NDH-4338 for treating chemical burns. Pharmaceutics. 2024;16(4):471.","journal-title":"Pharmaceutics"},{"key":"3151_CR31","doi-asserted-by":"publisher","first-page":"118829","DOI":"10.1016\/j.powtec.2023.118829","volume":"428","author":"FM Ca\u00f1ellas","year":"2023","unstructured":"Ca\u00f1ellas FM, Al-Rifai N, Padrela L, Tajber L, Khamiakova T, Otava M, Geertman R. A comparative study of dry and wet top-down milling approaches for the preparation of microparticle suspensions. Powder Technol. 2023;428:118829.","journal-title":"Powder Technol"},{"issue":"35","key":"3151_CR32","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.2174\/1381612811319350003","volume":"19","author":"K Moribe","year":"2013","unstructured":"Moribe K, Ueda K, Limwikrant W, Higashi K, Yamamoto K. Nano-sized crystalline drug production by milling technology. Curr Pharm Des. 2013;19(35):6246\u201358.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"3151_CR33","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3109\/10717544.2014.923066","volume":"23","author":"S Gora","year":"2016","unstructured":"Gora S, Mustafa G, Sahni JK, Ali J, Baboota S. Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study. Drug Deliv. 2016;23(3):940\u201350.","journal-title":"Drug Deliv"},{"issue":"6","key":"3151_CR34","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/10837450.2022.2098975","volume":"27","author":"X Ruan","year":"2022","unstructured":"Ruan X, Yu J, Miao H, Li R, Tong Z. Remdesivir powders manufactured by jet milling for potential pulmonary treatment of COVID-19. Pharm Dev Technol. 2022;27(6):635\u201345.","journal-title":"Pharm Dev Technol"},{"key":"3151_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.colsurfb.2012.01.047","volume":"95","author":"S Gahoi","year":"2012","unstructured":"Gahoi S, Jain GK, Tripathi R, Pandey SK, Anwar M, Warsi MH, Singhal M, Khar RK, Ahmad FJ. Enhanced antimalarial activity of lumefantrine nanopowder prepared by wet-milling DYNO MILL technique. Colloids Surf B Biointerfaces. 2012;95:16\u201322.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"22","key":"3151_CR36","doi-asserted-by":"publisher","first-page":"12406","DOI":"10.3390\/ijms222212406","volume":"22","author":"E Jakubowska","year":"2021","unstructured":"Jakubowska E, Milanowski B, Lulek J. A systematic approach to the development of cilostazol nanosuspension by Liquid Antisolvent Precipitation (LASP) and its combination with ultrasound. Int J Mol Sci. 2021;22(22):12406.","journal-title":"Int J Mol Sci"},{"key":"3151_CR37","doi-asserted-by":"publisher","first-page":"121089","DOI":"10.1016\/j.ijpharm.2021.121089","volume":"608","author":"R Kumar","year":"2021","unstructured":"Kumar R, Thakur AK, Banerjee N, Chaudhari P. A critical review on particle generation and other applications of rapid expansion of supercritical solution. Int J Pharm. 2021;608:121089.","journal-title":"Int J Pharm"},{"issue":"8","key":"3151_CR38","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/bioengineering11080788","volume":"11","author":"H Liu","year":"2024","unstructured":"Liu H, Liang X, Peng Y, Liu G, Cheng H. Supercritical fluids: an innovative strategy for drug development. Bioengineering (Basel). 2024;11(8):788.","journal-title":"Bioengineering (Basel)."},{"issue":"1\u20132","key":"3151_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.12.041","volume":"538","author":"SM Abuzar","year":"2018","unstructured":"Abuzar SM, Hyun SM, Kim JH, Park HJ, Kim MS, Park JS, Hwang SJ. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process. Int J Pharm. 2018;538(1\u20132):1\u201313.","journal-title":"Int J Pharm"},{"issue":"35","key":"3151_CR40","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1021\/acs.jafc.6b02197","volume":"64","author":"S Saelo","year":"2016","unstructured":"Saelo S, Assatarakul K, Sane A, Suppakul P. Fabrication of novel bioactive cellulose-based films derived from caffeic acid phenethyl ester-loaded nanoparticles via a rapid expansion process: RESOLV. J Agric Food Chem. 2016;64(35):6694\u2013707.","journal-title":"J Agric Food Chem"},{"issue":"1\u20132","key":"3151_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ijpharm.2015.03.027","volume":"485","author":"A Pestieau","year":"2015","unstructured":"Pestieau A, Krier F, Lebrun P, Brouwers A, Streel B, Evrard B. Optimization of a PGSS (particles from gas saturated solutions) process for a fenofibrate lipid-based solid dispersion formulation. Int J Pharm. 2015;485(1\u20132):295\u2013305.","journal-title":"Int J Pharm"},{"issue":"35","key":"3151_CR42","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1021\/ja046914t","volume":"126","author":"P Pathak","year":"2004","unstructured":"Pathak P, Meziani MJ, Desai T, Sun YP. Nanosizing drug particles in supercritical fluid processing. J Am Chem Soc. 2004;126(35):10842\u20133.","journal-title":"J Am Chem Soc"},{"issue":"2","key":"3151_CR43","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/polym11020244","volume":"11","author":"L Baldino","year":"2019","unstructured":"Baldino L, Cardea S, Reverchon E. Supercritical assisted electrospray: an improved micronization process. Polymers (Basel). 2019;11(2):244.","journal-title":"Polymers (Basel)"},{"issue":"4","key":"3151_CR44","first-page":"355","volume":"8","author":"SK Misra","year":"2020","unstructured":"Misra SK, Pathak K. Supercritical fluid technology for solubilization of poorly water soluble drugs via micro- and naonosized particle generation. ADMET DMPK. 2020;8(4):355\u201374.","journal-title":"ADMET DMPK"},{"issue":"6","key":"3151_CR45","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/pca.2968","volume":"31","author":"M Karimi","year":"2020","unstructured":"Karimi M, Raofie F. Preparation of Withaferin A nanoparticles extracted from Withania somnifera by the expansion of supercritical fluid solution. Phytochem Anal. 2020;31(6):957\u201367.","journal-title":"Phytochem Anal"},{"issue":"1","key":"3151_CR46","doi-asserted-by":"publisher","first-page":"14955","DOI":"10.1038\/s41598-024-64477-8","volume":"14","author":"M Bazaei","year":"2024","unstructured":"Bazaei M, Honarvar B, Esfandiari N, Sajadian SA, Arab Aboosadi Z. Preparation of Erlotinib hydrochloride nanoparticles (anti-cancer drug) by RESS-C method and investigating the effective parameters. Sci Rep. 2024;14(1):14955.","journal-title":"Sci Rep"},{"issue":"11","key":"3151_CR47","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/pharmaceutics16111471","volume":"16","author":"SK Sharma","year":"2024","unstructured":"Sharma SK, Palanikumar L, Pasricha R, Prakasam T, Magzoub M, Jagannathan R. Synthesis of self-assembled nanostructured cisplatin using the RESS process. Pharmaceutics. 2024;16(11):1471.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3151_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/polym16010029","volume":"16","author":"S Mottola","year":"2023","unstructured":"Mottola S, De Marco I. Supercritical antisolvent precipitation of corticosteroids\/\u03b2-cyclodextrin inclusion complexes. Polymers (Basel). 2023;16(1):29.","journal-title":"Polymers (Basel)"},{"issue":"3","key":"3151_CR49","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/pharmaceutics16030352","volume":"16","author":"S Mottola","year":"2024","unstructured":"Mottola S, De Marco I. Curcumin\/carrier coprecipitation by supercritical antisolvent route. Pharmaceutics. 2024;16(3):352.","journal-title":"Pharmaceutics"},{"issue":"8","key":"3151_CR50","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3109\/03639049809082724","volume":"24","author":"RO Williams","year":"1998","unstructured":"Williams RO, Repka M, Liu J. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler. Drug Dev Ind Pharm. 1998;24(8):763\u201370.","journal-title":"Drug Dev Ind Pharm"},{"issue":"27","key":"3151_CR51","first-page":"13633","volume":"15","author":"MM de Assis Ramos","year":"2024","unstructured":"de Assis Ramos MM, Ricardo-da-Silva FY, Macedo LO, Correia CJ, Moreira LFP, L\u00f6benberg R, Breithaupt-Faloppa AC, Bou-Chacra N. A review on lipid and polymeric nano-based 17-\u03b2-estradiol delivery systems: advances and challenges. J Pharm Sci. 2024;15(27):13633.","journal-title":"J Pharm Sci"},{"issue":"4","key":"3151_CR52","first-page":"50","volume":"8","author":"M Madhu","year":"2016","unstructured":"Madhu M, TNVSS S, Hephzibah G, Reddy TV. Validated RP-HPLC method for the determination of estradiol valerate in bulk and pharmaceutical formulations. Der Pharm Lett. 2016;8(4):50\u201361.","journal-title":"Der Pharm Lett"},{"issue":"1","key":"3151_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0378-5173(99)00134-9","volume":"186","author":"C Vervaet","year":"1999","unstructured":"Vervaet C, Byron PR. Drug-surfactant-propellant interactions in HFA-formulations. Int J Pharm. 1999;186(1):13\u201330.","journal-title":"Int J Pharm"},{"issue":"5","key":"3151_CR54","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acs.molpharmaceut.2c00095","volume":"19","author":"S Dedroog","year":"2022","unstructured":"Dedroog S, Adriaensens P, Van den Mooter G. Gaining insight into the role of the solvent during spray drying of amorphous solid dispersions by studying evaporation kinetics. Mol Pharm. 2022;19(5):1604\u201318.","journal-title":"Mol Pharm"},{"issue":"10","key":"3151_CR55","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1063\/1.863650","volume":"25","author":"RD Reitz","year":"1982","unstructured":"Reitz RD, Bracco FV. Mechanism of atomization of a liquid jet. Phys Fluids. 1982;25(10):1730\u201342.","journal-title":"Phys Fluids"},{"issue":"7","key":"3151_CR56","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1021\/ja00293a008","volume":"107","author":"WJ Albery","year":"1985","unstructured":"Albery WJ, Bartlett PN, Wilde CP, Darwent JR. A general model for dispersed kinetics in heterogeneous systems. J Am Chem Society. 1985;107(7):1854\u20138.","journal-title":"J Am Chem Society"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03151-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03151-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03151-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T17:02:59Z","timestamp":1751907779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03151-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3151"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03151-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"165"}}